CONNORS, J.M.,
SAVAGE, K.J,
JURCZAK, W,
LECH-MARANDA, E.,
SMOLEWSKI, P,
WALEWSKI, J,
STRAUS, D.J.,
YOUNES, A.,
ANSELL, S.M.,
KIM, W.S.,
GALLAMINI, A.,
ALEKSEEV, S.,
ILLÉS, A.,
ROSTA, A.,
PICARDI, M.,
ZINZANI, P.L.,
OKI, Y.,
FELDMAN, T.,
BARTLETT, N.L.,
CHEN, R.,
RAMCHANDREN, R.,
CUNNINGHAM, D.,
RADFORD, J.,
JOSEPHSON, N.C.,
SONG, E.,
SACHS, J.,
JOLIN, H.A.,
HUEBNER, D.,
LIU, R.,
LIPATOV, O.N. (2018) response and use of subsequent anticancer
therapy) as adjudicated by an independent review committee
Afolabi, A.,
Mustafina, I.,
Zhao, L.,
Li, L.,
Sun, R.,
Hu, S.,
Zhang, S.,
Jia, H.,
Guilio, G.,
Yu, B. (2018) of plaque progression to statin
therapy. Background: Previous studies showed that the presence of spotty
Zaplakhova, O. V.,
Nasibullin, T. R.,
Tuktarova, I. A.,
Timasheva, Y. R.,
Erdman, V. V.,
Bakhtiyarova, K. Z.,
Mustafina, O. E. (2018) 1109670*C/A (p = 0.017, OR = 2.06). In addition, using the APSampler algorithm, we identified
combinations